Replies to post #99661 on Ayala Pharmaceuticals Inc (ADXS)

[Harold_T_Solomon]

**** Note: my previous post on bankruptcy lacked due diligence - apologies

More information regarding viability, page 30 of SEC filing:

"As of April 30, 2019, we had approximately $33.7 million in cash and cash equivalents. Management’s plans to mitigate an expected shortfall of capital, to support future operations, include raising additional funds. It is our belief that we expect to have sufficient capital to fund our obligations, as they become due, in the ordinary course of business until January 2020."

So 6 months, hence the need to raise more funds. If it's not by a partner, time to punt.

Link: http://app.quotemedia.com/data/downloadFiling?webmasterId=91030&type=HTML&ref=12957839

[Bourbon_on_my_cornflakes]

FAKE MATH: No more BS-talk about "imminent/near-term bankruptcy"

Current burn rate was artificially low given AMGN was still funding trials.

Burn rate will rise given the commitments Ken said ADXS will make.

My guess is that he will end up basically structuring a dilution for anything considered viable, anything else will be gutted.

Dilution will be at $1.00 share with warrants getting it to $1.25 if they can find the vultures who will buy. Otherwise Ken will be angling for that Chapter 11 filing bonus.

Bartender is calling last round.

THE UNDERTAKER is thirsty again for a dilution bonus before he starts digging the grave.